WNK2 and chronic obstructive pulmonary disease: In fact, some signalling pathways can be altered in patients with severe pulmonary disease; specifically, higher expression of genes involved in inflammatory response-related signal transduction pathways, such as mitogen-activated protein kinase (MAPK), has been found in severe COPD patients [29].